Growth hormone and cancer: GH production and action in glioma? (Q52152223)

23 April 2018

title

Growth hormone and cancer: GH production and action in glioma? (English)

1 reference

23 April 2018

author name string

Robert W Lea

1

1 reference

23 April 2018

Timothy Dawson

2

1 reference

23 April 2018

Carlos G Martinez-Moreno

3

1 reference

23 April 2018

Nasra El-Abry

4

1 reference

23 April 2018

Steve Harvey

5

1 reference

23 April 2018

publication date

7 July 2015

1 reference

23 April 2018

General and Comparative Endocrinology

published in

1 reference

23 April 2018

volume

220

1 reference

23 April 2018

page(s)

119-123

1 reference

23 April 2018

Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone affects gene expression and proliferation in human prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone receptor; mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Hormones in the nucleus of mast cells: confocal microscopic immunocytochemical observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Elevated growth hormone levels in sera from breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Chemotherapy resistance of glioblastoma stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Recombinant rat and mouse growth hormones: risk assessment of carcinogenic potential in 2-year bioassays in rats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Extrapituitary growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Neural growth hormone: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Autocrine/paracrine roles of extrapituitary growth hormone and prolactin in health and disease: An overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Incidence of malignant tumors in patients with acromegaly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Colorectal neoplasia in acromegaly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

A correlation of endocrine and anticancer effects of some antagonists of GHRH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Association of a common polymorphism in the human GH1 gene with colorectal neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

The effects of recombinant human GH on promoting tumor growth depend on the expression of GH receptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Acromegaly and the risk of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Secretagogue induction of GH release in QNR/D cells: prevention of cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Insulin-like growth factor-I receptors in human glial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Differential effects of exogenous and autocrine growth hormone on LNCaP prostate cancer cell proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

The oncogenic potential of growth hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

The contribution of growth hormone to mammary neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone and cancer: an update on progress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Hypophysectomy in Treatment of Disseminated Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Adrenal histological change and liver-tumor inhibition in hypophysectomized rats fed the azo dye, 3'-methyl-4-dimethylaminoazobenzene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Treatment resistance mechanisms of malignant glioma tumor stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Multimeric growth hormone receptor complexes serve as signaling platforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Growth hormone enhances natural killer cell activity against glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Rational design of competitive prolactin/growth hormone receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Recurrence of sellar and suprasellar tumors in children treated with hGH--relation to immunohistochemical study on GH receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Autocrine growth hormone: effects on growth hormone receptor trafficking and signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

Proliferating cell unclear antigen-associated factor (PAF15): a novel oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGCEN.2015.06.011

10.1016/J.YGCEN.2015.06.011

7 January 2021

Identifiers

DOI

1 reference

23 April 2018

release_jke7eyjuwjf2tbkxmatapkbl4e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jke7eyjuwjf2tbkxmatapkbl4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 April 2018